These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26974966)

  • 1. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas.
    Lin RL; Wang TJ; Joyce CJ; Mihm MC; Murphy GF; Lian CG; Lin JY
    Melanoma Res; 2016 Oct; 26(5):524-7. PubMed ID: 26974966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five different scoring methods in the evaluation of inflammatory infiltration (tumor-infiltrating lymphocytes) in superficial spreading and nodular melanoma.
    Němejcová K; Tichá I; Bártů M; Kodet O; Důra M; Jakša R; Michálková R; Dundr P
    Pigment Cell Melanoma Res; 2019 May; 32(3):412-423. PubMed ID: 30506645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
    Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
    Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular primary cutaneous melanoma is associated with PD-L1 expression.
    Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Rodig S; Mihm M; Festa Neto C; Duncan LM; Kalil J
    Eur J Dermatol; 2020 Aug; 30(4):352-357. PubMed ID: 32969795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
    Schatton T; Scolyer RA; Thompson JF; Mihm MC
    Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.
    de Moll EH; Fu Y; Qian Y; Perkins SH; Wieder S; Gnjatic S; Remark R; Bernardo SG; Moskalenko M; Yao J; Ferringer T; Chang R; Chipuk J; Horst BA; Birge MB; Phelps RG; Saenger YM
    Cancer Immunol Immunother; 2015 Sep; 64(9):1193-203. PubMed ID: 26076664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
    Tas F; Erturk K
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.
    Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti G; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Paoli S; Bottoni U; Lo Scocco G; Scalvenzi M; Giannotti B
    Dermatol Surg; 2004 Nov; 30(11):1371-5; discussion 1375-6. PubMed ID: 15522016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
    Grotz TE; Vaince F; Hieken TJ
    Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
    Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
    Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.
    Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Muzikansky A; Kalil J; Festa-Neto C; Duncan LM
    J Immunol Res; 2015; 2015():761378. PubMed ID: 25954764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
    Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
    Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients.
    Tas F; Erturk K
    Cancer Invest; 2017 Sep; 35(8):501-505. PubMed ID: 28799813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients.
    Di Gennaro P; Gerlini G; Caporale R; Sestini S; Brandani P; Urso C; Pimpinelli N; Borgognoni L
    Cancer Lett; 2018 Mar; 417():124-130. PubMed ID: 29306022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.